A Phase 3, Multi-Center Study Evaluating PL9643 in Patients With Dry Eye
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This is a multi-center, double-masked, randomized, vehicle-controlled study testing PL9643,
an opthalmic solution to determine if safe and efficacious for dry eye patients.
After a 2-week run-in period, patients will be randomized equally to the PL9643 opthalmic
solution or vehicle opthalmic solution administered bilaterally three times a day for 12
weeks.
A Data Monitoring Committee will be engaged to review interim data.